Research Peptide SKU: EU-GLOWBPC

GLOW BPC-157 GHK-Cu TB-500

≥98% Purity Class-level spec; selected lots third-party tested
COA Available Batch report on request · HPLC identity check
Size 10mg = Lab report published

€39.99

1

Total: €39.99

Unavailable

Free shipping on orders over €200

  • If a product does not match the specification on its published COA, contact us with your batch number: we investigate against the lot report and replace any product that fails it, at no cost to you.
  • Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.

3–7 days most of the EU · 10–14 Nordics/Baltics

Standard EU from €4.99 · core EU GLS €17.99 · Dispatched within 1–2 business days · Free shipping over €200 · no customs paperwork (EU).

How Paysera and SEPA work

  1. Pay: send a manual SEPA transfer using the IBAN we email you, or approve a SEPA transfer via Paysera where offered.
  2. We confirm — Paysera notifies us instantly, or we match a manual transfer when it arrives (usually 1 business day).
  3. We dispatch — confirmed orders typically ship within 1–2 business days.

Card payments are not currently offered.

Research blend containing BPC-157, GHK-Cu and TB-500 for laboratory studies. For research purposes only. Not for human consumption.

Volume Pricing Applied automatically at checkout
Quantity Price Each Total Savings
1 unit €39.99 €39.99 —
3+ €37.99 €113.97 5% off
10+ €33.99 €339.92 15% off
Published reports

Laboratory reports are available for selected lots. Check each report for its result and stated method.

Third-Party Tested

Class-level specification on record; independent testing on selected lots.

Fast Shipping

Dispatched within 1–2 business days, shipping from €4.99 in the EU.

EU Dispatch

Ships across the EU plus Switzerland and the UK where permitted.

Last reviewed: 2026-11-03

Glow (BPC-157 / GHK-Cu / TB-500)

Glow is a fixed mixture of three research peptides in one vial: GHK-Cu 50 mg, BPC-157 10 mg, and TB-500 10 mg, 70 mg in total. It is not a single peptide. GHK-Cu is a copper-binding tripeptide, BPC-157 is a pentadecapeptide, and TB-500 is a thymosin beta-4 fragment, not the full-length protein. A fixed blend lets a protocol test the three together. It does not show that they act together, and findings on one component do not transfer to this vial.

Component Amount per vial
GHK-Cu 50mg
BPC-157 10mg
TB-500 10mg
Total 70mg

GLOW Stack for Laboratory Research

The GLOW stack provides a fixed combination for multi-peptide research involving pathways associated with tissue repair, cell migration and regeneration. Relevant experiments may examine collagen regulation, angiogenesis or how cells remodel the extracellular matrix.

GHK-Cu, BPC-157 and TB-500 have different identities and evidence bases. A study using the GLOW blend should therefore distinguish the behaviour of the complete formulation from responses to GHK-Cu, BPC-157 or TB-500 tested separately. Appropriate controls help researchers assess whether combining the components changes the measured response.

GHK-Cu: Copper Peptide Studies

GHK-Cu is a copper-binding tripeptide investigated in relation to cellular signalling, collagen production and matrix turnover. The GHK-Cu component accounts for most of the stated mass in this 70mg product.

In peptide research, GHK-Cu is relevant to questions about copper-dependent processes and how cells remodel surrounding structural proteins. Experimental conditions matter: copper availability, competing ligands and the composition of the culture medium can influence interpretation.

The inclusion of GHK-Cu does not establish that the complete GLOW peptide product produces skin regeneration or the same responses reported for GHK-Cu alone.

BPC-157: Experimental Repair Pathways

BPC-157 is a synthetic peptide investigated in preclinical studies involving tissue repair, cytoprotective responses and angiogenesis. These topics provide a rationale for studying BPC-157 in controlled research models, rather than establishing a guaranteed effect.

When assessing BPC-157 within the mixture, compare the combined preparation with BPC-157 alone where appropriate. The presence of GHK-Cu and TB-500 may introduce additional experimental variables. Concentration, exposure time and the selected measurements should match the question being investigated.

TB-500: Identity and Evidence

TB-500 is described as a thymosin beta-4 fragment associated with a sequence containing an actin-binding region. Confirm the precise identity in the supplier’s documentation: TB-500 and full-length thymosin beta-4 should not be treated as interchangeable. Findings about the parent molecule do not automatically demonstrate equivalent activity for the fragment.

For experiments combining TB-500 with BPC-157 and GHK-Cu, this distinction is essential when selecting references and interpreting cell-migration or regeneration measurements.

Quality Documentation for the GLOW Blend

Review the batch-specific certificate of analysis before selecting this research peptide. The COA should identify the tested material and explain the analytical methods supporting the reported results.

Quality check What to review
Component identity Evidence identifying GHK-Cu, BPC-157 and TB-500
Purity HPLC results and the method’s ability to distinguish the components
Composition Evidence supporting the stated quantities of GHK-Cu, BPC-157 and TB-500
Traceability Agreement between the COA, product label and supplied vial

A purity percentage alone does not verify the amount of each peptide or establish stability after mixing. Claims that the formulation enhances activity or lacks toxicity require evidence for the actual combination.

Intended Use

The GLOW peptide product is supplied for laboratory research use only. It is not intended for human or veterinary administration, therapeutic applications or cosmetic use.

Handle the vial according to documented procedures and evaluate each compound within appropriate research settings. A fixed combination can support experimental comparisons, but it does not guarantee tissue repair or a particular biological outcome.